Capsid inhibitors for the treatment of HIV
US11944611B2 · kind B2 · utility
4Cited by
47References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2019 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Jun 4, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of Formula (Ia) and (Ib): or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.